Study findings indicate that environmentally relevant doses of OLA bioplastics may be “more toxic” to the placenta than ...

GEN Live panelists will explore how stem cells are transforming disease modeling, drug discovery, and personalized medicine with perspectives on clinical trial progress and hurdles such as ...

Researchers suggest modulating intestinal microbiota or antigen-presenting activity of IECs represents new approaches to treating autoimmune neurological disease.

The data shows that inhibiting TIE2 with rebastinib could prevent new abnormalities from forming in the brain with fewer side effects.

Beyond resistance‑associated genes, the researchers uncovered deep geographic population structure and high overall genetic diversity.

The data showed that roughly 65% of the cells in the oxygenated devices remained viable compared to roughly 20% in control devices.

Whether Judge Murphy’s ruling holds through appeal will determine how much institutional credibility can be recovered.

Many organizations still lack structured media optimization and alignment between development and manufacturing, according to Lonza.

UCB has achieved 15 FDA approvals or indication expansions, nine of which were secured in the past three years.

The connection between cancer response and autoimmune disease in the brain lies with the antibodies deployed to fight cancer.

A new approach engineers immune cells to recognize byproducts of cancer cells to trigger migration toward the tumor.

Realizing the benefits of regenerative medicine will require a structural shift toward earlier detection and therapeutic intervention.